PEGINTRON (peginterferon alfa-2b) Vials
Status: Discontinuation
» Therapeutic Categories: Antiviral
Merck Sharp & Dohme Corp. (New 09/24/2015)
|
Presentation |
Posting Date |
Related Information |
| PEGINTRON (peginterferon alfa-2b) injection, 50 mcg per 0.5 mL (NDC 00085-4353-01) | 09/24/2015 | For business reasons, Merck has decided to voluntarily discontinue the manufacture of PEGINTRON vials, Injection, for subcutaneous use, for distribution in the United States, effective date of February 1, 2016. |
| PEGINTRON (peginterferon alfa-2b) injection, 80 mcg per 0.5 mL (NDC 00085-4354-01) | 09/24/2015 | For business reasons, Merck has decided to voluntarily discontinue the manufacture of PEGINTRON vials, Injection, for subcutaneous use, for distribution in the United States, effective date of February 1, 2016. |
| PEGINTRON (peginterferon alfa-2b) injection, 120 mcg per 0.5 mL (NDC 00085-4355-01) | 09/24/2015 | For business reasons, Merck has decided to voluntarily discontinue the manufacture of PEGINTRON vials, Injection, for subcutaneous use, for distribution in the United States, effective date of February 1, 2016. |
| PEGINTRON (peginterferon alfa-2b) injection, 150 mcg per 0.5 mL (NDC 00085-4356-01) | 09/24/2015 | For business reasons, Merck has decided to voluntarily discontinue the manufacture of PEGINTRON vials, Injection, for subcutaneous use, for distribution in the United States, effective date of February 1, 2016. |